215 related articles for article (PubMed ID: 29886124)
21. The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer.
Martínez-Bosch N; Guerrero PE; Moreno M; José A; Iglesias M; Munné-Collado J; Anta H; Gibert J; Orozco CA; Vinaixa J; Fillat C; Viñals F; Navarro P
Oncotarget; 2016 Jul; 7(30):48265-48279. PubMed ID: 27374084
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
Diana A; Wang LM; D'Costa Z; Azad A; Silva MA; Soonawalla Z; Allen P; Liu S; McKenna WG; Muschel RJ; Fokas E
Oncotarget; 2016 Nov; 7(45):72819-72832. PubMed ID: 27637082
[TBL] [Abstract][Full Text] [Related]
23. Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Hompland T; Mathiesen B; Rofstad EK
Radiother Oncol; 2012 Mar; 102(3):429-35. PubMed ID: 22197352
[TBL] [Abstract][Full Text] [Related]
24. Dynamic Contrast-enhanced MRI Detects Responses to Stroma-directed Therapy in Mouse Models of Pancreatic Ductal Adenocarcinoma.
Cao J; Pickup S; Clendenin C; Blouw B; Choi H; Kang D; Rosen M; O'Dwyer PJ; Zhou R
Clin Cancer Res; 2019 Apr; 25(7):2314-2322. PubMed ID: 30587546
[TBL] [Abstract][Full Text] [Related]
25. Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice.
Matsumoto S; Kishimoto S; Saito K; Takakusagi Y; Munasinghe JP; Devasahayam N; Hart CP; Gillies RJ; Mitchell JB; Krishna MC
Cancer Res; 2018 Jul; 78(14):3783-3792. PubMed ID: 29792309
[TBL] [Abstract][Full Text] [Related]
26. Connective tissue of cervical carcinoma xenografts: associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI.
Hompland T; Ellingsen C; Galappathi K; Rofstad EK
Acta Oncol; 2014 Jan; 53(1):6-15. PubMed ID: 23445339
[TBL] [Abstract][Full Text] [Related]
27. Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma.
Olson P; Chu GC; Perry SR; Nolan-Stevaux O; Hanahan D
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1275-84. PubMed ID: 22084065
[TBL] [Abstract][Full Text] [Related]
28. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
29. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma.
Muñoz NM; Minhaj AA; Maldonado KL; Kingsley CV; Cortes AC; Taghavi H; Polak U; Mitchell JM; Ensor JE; Bankson JA; Rashid A; Avritscher R
Magn Reson Imaging; 2019 Apr; 57():156-164. PubMed ID: 30465870
[TBL] [Abstract][Full Text] [Related]
30. MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts.
Zhang X; Wojtkowiak JW; Martinez GV; Cornnell HH; Hart CP; Baker AF; Gillies R
PLoS One; 2016; 11(5):e0155289. PubMed ID: 27227903
[TBL] [Abstract][Full Text] [Related]
31. DCE-MRI of Tumor Hypoxia and Hypoxia-Associated Aggressiveness.
Gaustad JV; Hauge A; Wegner CS; Simonsen TG; Lund KV; Hansem LMK; Rofstad EK
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32698525
[TBL] [Abstract][Full Text] [Related]
32. Impact of Arterial Input Function and Pharmacokinetic Models on DCE-MRI Biomarkers for Detection of Vascular Effect Induced by Stroma-Directed Drug in an Orthotopic Mouse Model of Pancreatic Cancer.
Cao J; Pickup S; Rosen M; Zhou R
Mol Imaging Biol; 2023 Aug; 25(4):638-647. PubMed ID: 37166575
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
[TBL] [Abstract][Full Text] [Related]
34. Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment.
Sun X; Ackerstaff E; He F; Xing L; Hsiao HT; Koutcher JA; Ling CC; Li GC
Oncotarget; 2015 Oct; 6(33):34732-44. PubMed ID: 26416246
[TBL] [Abstract][Full Text] [Related]
35. Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.
Røe K; Mikalsen LT; van der Kogel AJ; Bussink J; Lyng H; Ree AH; Marignol L; Olsen DR
Radiat Oncol; 2012 May; 7():75. PubMed ID: 22621752
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
Guimaraes AR; Rakhlin E; Weissleder R; Thayer SP
Pancreas; 2008 Nov; 37(4):440-4. PubMed ID: 18953259
[TBL] [Abstract][Full Text] [Related]
37. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
[TBL] [Abstract][Full Text] [Related]
38. Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging.
Gulliksrud K; Hompland T; Galappathi K; Rofstad EK
Radiother Oncol; 2011 Oct; 101(1):217-22. PubMed ID: 21840612
[TBL] [Abstract][Full Text] [Related]
39. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]